Marshall Wace North America’s NEVRO CORP. NVRO Stock Holding History

Marshall Wace North America’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-39,244	Closed	-$6.51M	–	1774
2021 Q2	$6.51M	Sell	39,244 -87,537	-69%	-$13.7M	0.03%	478
2021 Q1	$17.7M	Sell	126,781 -306,790	-71%	-$50.1M	0.07%	274
2020 Q4	$75.1M	Buy	+433,571	New	+$70.2M	0.34%	68
2019 Q2	–	Sell	-4,390	Closed	-$276K	–	1690
2019 Q1	$276K	Buy	4,390 +941	+27%	+$44.2K	﹤0.01%	914
2018 Q4	$134K	Buy	+3,449	New	+$153K	﹤0.01%	1033
2017 Q3	–	Sell	-12,046	Closed	-$891K	–	1547
2017 Q2	$891K	Buy	12,046 +6,958	+137%	+$557K	0.01%	962
2017 Q1	$478K	Buy	+5,088	New	+$461K	﹤0.01%	823

Other funds holding NVRO

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Marshall Wace North America's NVRO Position: Q3 2021 in Review

Marshall Wace North America sold out of NEVRO CORP. (NVRO) in Q3 2021, closing a stake of 39,244 shares — an estimated $6.51M sold.

Marshall Wace North America first reported a position in NVRO in Q1 2017 and held it in 7 quarters. The position peaked at $75.1M in Q4 2020. 194 funds tracked by Wall St. Rank hold NVRO as of Q3 2021.

Marshall Wace North America reported no remaining NEVRO CORP. position as of Q3 2021 after selling out during the quarter.
Marshall Wace North America sold 39,244 NEVRO CORP. shares in Q3 2021, an estimated $6.51M.
Marshall Wace North America first reported a position in NEVRO CORP. in Q1 2017 and held it in 7 quarters.
Marshall Wace North America's NEVRO CORP. position peaked at $75.1M in Q4 2020.
194 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.